Concepedia

Author

Junko H. Ohyashiki

Tokyo Medical UniversityORCID

Also Known As

J H Ohyashiki, J Ohyashiki, J. H. OHYASHIKI, J. H. Ohyashiki, J. Ohyashiki, J.H. Ohyashiki, JUNKO H. OHYASHIKI, Junko H Ohyashiki, Junko H. OHYASHIKI, Junko H. Ohyashiki

244

Publications

6.6K

Citations

37

H-Index

105

Concepts

All Affiliations

Tokyo Medical UniversityRoswell Park Comprehensive Cancer CenterAsahikawa Medical College HospitalTokyo Medical and Dental UniversityKeio University
JH

About

Junko H. Ohyashiki is an author at Tokyo Medical University specializing in medicine, cell biology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

61

2.5K

2

Health Sciences

10

11

474

3

Natural Sciences

5

5

168

4

Engineering

1

1

83

5

Public Health

1

1

36

Junko H. Ohyashiki

×

99

Publications

5.5K

Citations

36

H-Index

YearCitations

Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1

Tomohiro Umezu, Hiroko Tadokoro, Kenko Azuma,

Blood

2014

587

Leukemia cell to endothelial cell communication via exosomal miRNAs

Tomohiro Umezu, Kazuma Ohyashiki, Masahiko Kuroda,

Oncogene

2012

444

Exosomes Derived from Hypoxic Leukemia Cells Enhance Tube Formation in Endothelial Cells

Hiroko Tadokoro, Tomohiro Umezu, Kazuma Ohyashiki,

Journal of Biological Chemistry

2013

356

Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients

Masami Tanaka, Kosuke Oikawa, Masakatsu Takanashi,

PLoS ONE

2009

295

Telomeric length and telomerase activity vary with age in peripheral blood cells obtained from normal individuals

Hiroshi Iwama, Kazuma Ohyashiki, Junko H. Ohyashiki,

Human Genetics

1998

261

Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia

Tetsuzo Tauchi, Kazuo Shin‐ya, Goro Sashida,

Oncogene

2006

219

Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways

Tetsuzo Tauchi, Kazuo Shin‐ya, Goro Sashida,

Oncogene

2003

203

The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1

Junko H. Ohyashiki, Chiaki Kobayashi, Ryoko Hamamura,

Cancer Science

2009

133

Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes.

Junko H. Ohyashiki, Kazuma Ohyashiki, Toshikatsu Fujimura,

PubMed

1994

128

Cytogenetics in Myelodysplastic Syndromes

Kazuma Ohyashiki, Atsushi Kodama, Junko H. Ohyashiki

Methods in molecular biology

2011

113

Page 1